Atlas Trials

Clostridium Difficile Vaccine Safety, Tolerability, and Immunogenicity Study in Japanese Adults

Clinical trial NCT02725437 · COMPLETED

Trial details

NCT number
NCT02725437
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Clostridium Difficile Associated Disease
Start date
2016-02-01
Primary completion
2017-02-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.